What Neogen Corporation told the SEC could break it.

A significant portion of Neogen's products and revenues are affected by the regulations of domestic and foreign government agencies — the USDA, EPA and FDA in the U.S. (its rodent/insect-control and disinfectant products require EPA registration; food-safety and animal-health products require USDA/FDA approvals and use of FDA-registered facilities). Changes in these regulations could affect revenues and/or costs of production and distribution, and its processes involve regulated hazardous materials/chemicals. Adverse regulatory changes, registration delays, or loss of an approval/validation would restrict the products it can sell. A specific, multi-agency product-registration regulatory exposure.

“A significant portion of Neogen's products and revenues are affected by the regulations of various domestic and foreign government agencies, including the U.S. Department of Agriculture (USDA), the Environmental Protection Agency (EPA), and the U.S. Food and Drug Administration (FDA).”

Neogen purchases components and raw materials from many suppliers, often single-sourcing items for volume discounts, and currently buys some raw materials and products from sole/single sources — some proprietary and therefore not readily replaceable. Certain of its food-safety product lines depend on a sole or single-source supplier or vendor whose ability to deliver could be disrupted by quality issues, facility relocation, work stoppages, public-health events, or contractual failures. While it believes alternatives exist for most key items, a disruption at a sole-source supplier of a proprietary reagent/component could interrupt its diagnostic-kit supply and reduce sales. The suppliers are not named (apart from the 3M FSD manufacturing edge), so this is a sole-source dependence risk. A real proprietary-input single-source vulnerability.

“Certain of our food safety product lines depend on a sole or single source supplier or vendor.”